NGE On Demand: COVID-19 and IP Waiver for Patent Protection with Kevin O'Connor and Olivia Luk Bedi

Neal, Gerber & Eisenberg LLP
Contact
Recently, the U.S.’s changed position on IP Waiver for patent protection of the COVID-19 vaccines and technology grabbed the headlines. It was an about-face from its previous stance. But what does it all mean?

From Facebook posts to conversations at the pickup line, it seems people don’t really understand what this IP Waiver means at all. Listen to this Olivia and Kevin explain what this news is all about.

Embed
Copy

Other MultiMedia by Neal, Gerber & Eisenberg LLP

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Neal, Gerber & Eisenberg LLP

Written by:

Neal, Gerber & Eisenberg LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Neal, Gerber & Eisenberg LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide